Systems and Methods for Mastopexy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/451,103, filed Mar 9, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,277,986 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | ||
| US 9,585,744 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | ||
| US 10,258,460 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | ||
| US 10,765,507 | Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | ||
| US 8,858,629 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | ||
| US 11,744,696 | Implants and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | ||
| Application 18/355,061 | Implants and Methods for Mastopexy Pending Not granted | Tepha, Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Tepha, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.